Takeda's Partner Merges With Crestovo to Form Finch Therapeutics Group Post author:Sam Post published:October 22, 2017 Post category:BioPharma Two privately-held biotechs have merged to tackle recurrent C. difficile infections. Source: BioSpace You Might Also Like NeuralStem Announces Pricing Of Public Offering Of Common Stock And Warrants July 26, 2017 CryoLife Announces Release Date And Teleconference Call Details For 2017 First Quarter Financial Results April 10, 2017 San Diego's Halozyme Lands Potential $680M R&D Deal With Alexion December 6, 2017
CryoLife Announces Release Date And Teleconference Call Details For 2017 First Quarter Financial Results April 10, 2017
